$2.5T
Total marketcap
$76.65B
Total volume
BTC 50.91%     ETH 15.11%
Dominance

STAAR Surgical Company STAA Stock

49.79 USD {{ price }} -3.507747% {{change_pct}}%
Exchange
NasdaqGM
Market Cap
2.43B USD
LOW - HIGH [24H]
48.76 - 51.34 USD
VOLUME [24H]
682.34K USD
{{ volume }}
P/E Ratio
115.79
Earnings per share
0.43 USD

STAAR Surgical Company Price Chart

STAAR Surgical Company STAA Financial and Trading Overview

STAAR Surgical Company stock price 49.79 USD
Previous Close 50.48 USD
Open 50.02 USD
Bid 0 USD x 1000
Ask 0 USD x 800
Day's Range 49.65 - 52.79 USD
52 Week Range 46.36 - 112.27 USD
Volume 644.81K USD
Avg. Volume 618.84K USD
Market Cap 2.55B USD
Beta (5Y Monthly) 1.179577
PE Ratio (TTM) 84.95161
EPS (TTM) 0.43 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 78.22 USD

STAA Valuation Measures

Enterprise Value 2.27B USD
Trailing P/E 84.95161
Forward P/E 47.881817
PEG Ratio (5 yr expected) 3.06
Price/Sales (ttm) 8.637752
Price/Book (mrq) 7.510338
Enterprise Value/Revenue 7.695
Enterprise Value/EBITDA 57.6

Trading Information

STAAR Surgical Company Stock Price History

Beta (5Y Monthly) 1.179577
52-Week Change -16.93%
S&P500 52-Week Change 20.43%
52 Week High 112.27 USD
52 Week Low 46.36 USD
50-Day Moving Average 62.71 USD
200-Day Moving Average 66.1 USD

STAA Share Statistics

Avg. Volume (3 month) 618.84K USD
Avg. Daily Volume (10-Days) 1.06M USD
Shares Outstanding 48.33M
Float 39.2M
Short Ratio 10.11
% Held by Insiders 0.72%
% Held by Institutions 101.89%
Shares Short 6.3M
Short % of Float 27.26%
Short % of Shares Outstanding 13.02%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor 1:2

Financial Highlights

Fiscal Year

Fiscal Year Ends December 30, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 30, 2023

Profitability

Profit Margin 10.81%
Operating Margin (ttm) 11.77%
Gross Margin 78.61%
EBITDA Margin 13.35%

Management Effectiveness

Return on Assets (ttm) 5.63%
Return on Equity (ttm) 10.35%

Income Statement

Revenue (ttm) 294.72M USD
Revenue Per Share (ttm) 6.13 USD
Quarterly Revenue Growth (yoy) 16.30%
Gross Profit (ttm) 223.38M USD
EBITDA 39.37M USD
Net Income Avi to Common (ttm) 31.86M USD
Diluted EPS (ttm) 0.62
Quarterly Earnings Growth (yoy) -71.79%

Balance Sheet

Total Cash (mrq) 203.85M USD
Total Cash Per Share (mrq) 4.22 USD
Total Debt (mrq) 31.91M USD
Total Debt/Equity (mrq) 9.41 USD
Current Ratio (mrq) 6.648
Book Value Per Share (mrq) 7.013

Cash Flow Statement

Operating Cash Flow (ttm) 35.23M USD
Levered Free Cash Flow (ttm) 8.17M USD

Profile of STAAR Surgical Company

Country United States
State CA
City Lake Forest
Address 25651 Atlantic Ocean Drive
ZIP 92630
Phone 626 303 7902
Website https://www.staar.com
Industry Medical Instruments & Supplies
Sector(s) Healthcare
Full Time Employees 882

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides Visian implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia; and Hyperopic ICL, which treats far-sightedness. It also offers preloaded silicone cataract intraocular lenses and injector systems for use in cataract surgery. In addition, the company sells injector parts, and other related instruments and devices. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.

Q&A For STAAR Surgical Company Stock

What is a current STAA stock price?

STAAR Surgical Company STAA stock price today per share is 49.79 USD.

How to purchase STAAR Surgical Company stock?

You can buy STAA shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for STAAR Surgical Company?

The stock symbol or ticker of STAAR Surgical Company is STAA.

Which industry does the STAAR Surgical Company company belong to?

The STAAR Surgical Company industry is Medical Instruments & Supplies.

How many shares does STAAR Surgical Company have in circulation?

The max supply of STAAR Surgical Company shares is 48.87M.

What is STAAR Surgical Company Price to Earnings Ratio (PE Ratio)?

STAAR Surgical Company PE Ratio is 115.79069500 now.

What was STAAR Surgical Company earnings per share over the trailing 12 months (TTM)?

STAAR Surgical Company EPS is 0.43 USD over the trailing 12 months.

Which sector does the STAAR Surgical Company company belong to?

The STAAR Surgical Company sector is Healthcare.

STAAR Surgical Company STAA included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16175.09 USD
-1.62
3.94B USD 16125.33 USD 16341.46 USD 3.94B USD
NASDAQ Global Market Composite NQGM 2160.36 USD
-2.45
2147.48 USD 2200.33 USD
NASDAQ Composite Total Return I XCMP 19659.36 USD
-1.62
19598.88 USD 19861.56 USD
Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG 2541.54 USD
-1.89
2531.95 USD 2572.66 USD
NASDAQ HealthCare IXHC 958.68 USD
-2.07
954.08 USD 972.42 USD